Seven-Year Surveillance of the Clinical Performance of a Blood Glucose Test Strip Product
- 13 April 2017
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 11 (6), 1155-1162
- https://doi.org/10.1177/1932296817703133
Abstract
Background: A key approach in enabling people with diabetes to better manage their condition is through self-monitoring of blood glucose (SMBG). Any functional SMBG system should demonstrate clinical accuracy across a broad glucose range and be insensitive to hematocrit. Furthermore, it should be incumbent on the manufacturer to demonstrate that their product continues to meet clinical accuracy claims during product lifetime. Methods: Test strips from a globally distributed SMBG product were sampled from randomly selected production batches as part of the manufacturer’s routine product evaluation process. Clinical accuracy was assessed within diabetes patients at 3 clinic sites against a standard reference method and evaluated against system accuracy in accordance with the ISO 15197:2015 standard (unchanged from ISO 15197:2013 in terms of performance specifications). Data were collected over 7 years (2010-2016) and comprised 73,600 individual glucose results. Overall clinic performance was assessed, as was accuracy at low and high glucose levels and extremes of hematocrit. Results: Across the 7-year surveillance period, overall test strip clinical accuracy was 97.8% versus the 95% ISO-defined minimum criterion with by-year values of 97.0-98.6%. Accuracy at the lowest (≤50 mg/dL) and highest (>400 mg/dL) ranges of glucose was 97.0% and 98.3% respectively. Within these low/high blood glucose subpopulations, accuracy at the lower and upper first percentile hematocrit ranges, was 98.9%, and 97.1% respectively. Conclusions: This 7-year surveillance program showed the test strips to have excellent clinical accuracy at the outer ranges of subject blood glucose and hematocrit, based on assessment against the ISO 15197:2015 clinical accuracy criterion.Keywords
Funding Information
- LifeScan Scotland Ltd., UK
This publication has 19 references indexed in Scilit:
- RETRACTED:Evaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes ClinicDiabetes Technology & Therapeutics, 2016
- Development of the Diabetes Technology Society Blood Glucose Monitor System Surveillance ProtocolJournal of Diabetes Science and Technology, 2015
- A comprehensive evaluation of strip performance in multiple blood glucose monitoring systemsExpert Review of Medical Devices, 2015
- Analytic Characteristics of Three Bayer Contour Blood Glucose Monitoring Systems in NeonatesJournal of Diabetes Science and Technology, 2014
- Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine SocietyDiabetes Care, 2013
- Clinical evaluation of a novel test strip technology for blood glucose monitoring: Accuracy at hypoglycaemic glucose levelsDiabetes Research and Clinical Practice, 2012
- A Comprehensive Evaluation of the Performance of the Test Strip Technology for OneTouch Verio Glucose Meter SystemsDiabetes Technology & Therapeutics, 2012
- Editor's introductionDiabetes/Metabolism Research and Reviews, 2010
- Blood Pressure and Hematocrit in Diabetes and the Role of Endothelial Responses in the Variability of Blood ViscosityDiabetes Care, 2006
- The Electric Capacity of Suspensions of Red Corpuscles of a DogPhysical Review B, 1925